
Izvēlieties etiķeti
redzama tieši uz flakonaLaboratorijas ziņojums
PDF- Pārbaudīts
- BPC + TB Blend 10mg (5+5)
- Laboratorija
- Analiza Białek
- Datums
- October 2026
- Rezultāts
- 99% purity (BPC-157 5.47 mg + TB-500 5.29 mg)
- Endotoksīni
- 6.00 EU/vial
- Pasūtījuma nr.
- Parole
Neatkarīgi pārbaudīts, ar paroli pārbaudāms tieši laboratorijā.
BPC + TB Blend
Healing
- Laboratorijā pārbaudīts · 99% tīrība
- Sūtām no Vācijas
Pasūtījums
- DHL ar izsekošanu
- Diskrēts iepakojums
Īsumā
BPC + TB Blend skaitļos
Galvenie rādītāji no mūsu leksikona.
Pilns leksikona ieraksts- Class
- Healing blendBPC-157 + TB-500
- Use
- Subcutaneousin mg, half/half
- Sizes
- 10 to 30 mg3 sizes in the shop
What studies show
The source in the lexicon- Crockford et al., Annals of the New York Academy of Sciences, 2010
Zināšanas
Viss par BPC + TB Blend
Detalizēta informācija drīzumā.
Dozēšana
Ielādē dozēšanas informāciju …
Noderēs
Kas jums vēl būs vajadzīgs
Bakteriostatiskais ūdens tiek automātiski pievienots grozam. Šļirces un salvetes - ar vienu klikšķi.
Insulīna šļirces
10 gab. · 5.50 €
Spirta salvetes
50 gab. · 10 €
Cik daudz ūdens?
Vienības uz šļirces jūsu flakona izmēram.
Atvērt kalkulatoru →Are there studies on the ready-made blend?
No. As of 26 October 2026 there is no trial with BPC-157 and TB-500 together on ClinicalTrials.gov. PubMed has one rat study on the Achilles tendon and three case reports on jaw nerve damage in which several peptides and other agents were given together. Cause and effect cannot be derived from them.
Do both work better together?
That is not established. In 32 rats with a repaired Achilles tendon each on its own was linked to better tendon tissue, significantly above all with TB-500, which also raised tensile strength. The combination gave no advantage over either alone. The authors suspect that both feed into the same signalling pathways.
What is TB-500?
TB-500 is sold as a fragment of thymosin beta-4. Thymosin beta-4 is the main peptide that binds free actin in cells and is linked to cell migration, new vessel formation and tissue repair. A 2026 review finds hardly any solid human safety data for TB-500.
How are the two components thought to work?
BPC-157 raised the receptor VEGFR2 and new vessel formation in vessel cells. Thymosin beta-4 carries its vessel-forming effect in its actin-binding motif and sped up wound healing in rats. Both come from cell and animal experiments.
Which trials exist on the components?
Thymosin beta-4 was given into a vein in phase 2 after heart attack and tested earlier as a gel for pressure and leg ulcers, a third heart trial has been announced. For BPC-157 a phase 1 trial after shoulder surgery is planned, a study with gummies was completed without results.
Which side effects are known?
None for the blend. No treatment-related side effects occurred in the three small human studies on BPC-157, but the certainty is very low. 40 healthy people tolerated thymosin beta-4 into a vein without serious side effects. One review warns of risks from unregulated manufacturing.
Saistītie
Saistītie produkti
BPC-157
Peptīdi · Dziedēšana un atjaunošanās Dziedēšana un atjaunošanās
4 izmēri
Laboratorijā pārbaudīts
= no 5.2 €/flakons
TB-500 (Thymosin B4)
Peptīdi · Dziedēšana un atjaunošanās Dziedēšana un atjaunošanās
3 izmēri
Laboratorijā pārbaudīts
= no 18.8 €/flakons
TB-500 FRAG
Peptīdi · Dziedēšana un atjaunošanās Dziedēšana un atjaunošanās
1 izmērs
= 24.8 €/flakons
BPC + TB + KPV Blend
Peptīdi · Dziedēšana un atjaunošanās Dziedēšana un atjaunošanās
1 izmērs
= 52 €/flakons
BPC + TB Blend